Today, Indian frankincense and its extracts are used for various chronic inflammatory problems such as arthritis, asthma, IBS, ulcerative colitis, Crohn's disease, and brain edema. The mechanism of anti-inflammatory activity of the Boswellia extract is due to the boswellic acids,
which have been identified as the active principle of frankincense. The chemical structure of boswellic acids closely resembles that of steroids, but their actions are different from painkillers or nonsteroidal anti-inflammatory drugs (NSAIDs) and are related to the component of the immune system and the inhibition of 5 lipoxygenase.
Effective in managing symptoms of IBS and Crohn’s disease, such as pain, cramps, and altered bowel movements
Anti-diarrheal, without inducing constipation
Used to reduce inflammation in arthritis, chronic bowel disease, asthma and related inflammatory diseases
Enterocap is a purified concentrate of triterpenoid acids from Indian frankincense (Boswellia serrata) bound to sunflower phosphatidyl choline (PC) .It has been used in a four week, 43 patient observational study with ulcerative colitis patients. Diffuse abdominal pain, bowel movements Intestinal cramps, watery stools, anemia, rectal irritation, and occult blood were all improved in the Enterocap group. Fecal concentration of calprotectin, a marker of bowel inflammation was reduced thus suggesting that Enterocap can maintain colitis patients in remission.
Enterocap has also been studied in IBS patients. In a four week, 71 patient study comparing two different medications to the herbal formula Enterocap, patients showed improvement in abdominal pain, cramping, altered bowel movements, and intestinal gas. In summary: Enterocap can normalize intestinal motility and has antidiarrheal activity; Boswellia serrata extract with PC optimizes the delivery to smooth muscles including the stomach intestines, blood vessels and urinary bladder; Enterocap can be used with collagen supplementation such as Collagenex 2 for joint pain and tendon inflammation.